Device center studying adverse events related to children
This article was originally published in The Silver Sheet
CDRH is conducting an in-depth study of adverse events with medical devices in younger patients, the first part of which was published online July 26 in the journal Pediatrics. FDA staffers analyzed visits to 100 U.S. emergency rooms between Jan. 1, 2004, and Dec. 21, 2005, by patients 21 years old or younger. Most device-related adverse events involve Class II, moderate-risk devices, according to results presented in the article. The 144,799 identified events involved devices from 13 medical specialties, including ophthalmology, cardiology and radiology, but the researchers concluded that it was two product categories that primarily contributed to the public health burden: ophthalmic devices - notably contact lenses - and physical medicine devices
You may also be interested in...
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.
Pharmaceutical companies struggling to keep up with coronavirus-related supply chain havoc asked to keep the US regulator informed as situation unfolds.